Related references
Note: Only part of the references are listed.Beyond VEGF: Inhibition of the Fibroblast Growth Factor Pathway and Antiangiogenesis
Christopher Lieu et al.
CLINICAL CANCER RESEARCH (2011)
Bone Marrow Fat Is Inversely Related to Cortical Bone in Young and Old Subjects
Tishya A. L. Wren et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
PDGF in Bone Formation and Regeneration: New Insights into a Novel Mechanism Involving MSCs
Arnold I. Caplan et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2011)
Drilled Hole Defects in Mouse Femur as Models of Intramembranous Cortical and Cancellous Bone Regeneration
Laurent Monfoulet et al.
CALCIFIED TISSUE INTERNATIONAL (2010)
The Peroxisome Proliferator-Activated Receptor-γ Agonist Rosiglitazone Increases Bone Resorption in Women with Type 2 Diabetes: A Randomized, Controlled Trial
Ugis Gruntmanis et al.
CALCIFIED TISSUE INTERNATIONAL (2010)
PGC1β Mediates PPARγ Activation of Osteoclastogenesis and Rosiglitazone-Induced Bone Loss
Wei Wei et al.
CELL METABOLISM (2010)
PPARγ in Placental Angiogenesis
Karim Nadra et al.
ENDOCRINOLOGY (2010)
Thiazolidinedione Use and the Longitudinal Risk of Fractures in Patients with Type 2 Diabetes Mellitus
Zeina A. Habib et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes
Bernard Zinman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Mesenchymal Stem Cells Expressing Osteogenic and Angiogenic Factors Synergistically Enhance Bone Formation in a Mouse Model of Segmental Bone Defect
Sanjay Kumar et al.
MOLECULAR THERAPY (2010)
Bone Loss in Diabetes: Use of Antidiabetic Thiazolidinediones and Secondary Osteoporosis
Beata Lecka-Czernik
Current Osteoporosis Reports (2010)
PPARs in Bone: The Role in Bone Cell Differentiation and Regulation of Energy Metabolism
Beata Lecka-Czernik
Current Osteoporosis Reports (2010)
Diabetes and Its Complications and Their Relationship with Risk of Fractures in Type 1 and 2 Diabetes
Peter Vestergaard et al.
CALCIFIED TISSUE INTERNATIONAL (2009)
Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis
Yoon K. Loke et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2009)
PPARγ2 Nuclear Receptor Controls Multiple Regulatory Pathways of Osteoblast Differentiation From Marrow Mesenchymal Stem Cells
Keith R. Shockley et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Fat and beyond: The diverse biology of PPAR gamma
Peter Tontonoz et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2008)
Use of thiazolidinediones and fracture risk
Christian Meier et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Rosiglitazone-associated fractures in type 2 diabetes - An analysis from a diabetes outcome progression trial (ADOPT)
Steven E. Kahn et al.
DIABETES CARE (2008)
Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis
Z. S. Ai-Aql et al.
JOURNAL OF DENTAL RESEARCH (2008)
PPAR-γ regulates osteoclastogenesis in mice
Yihong Wan et al.
NATURE MEDICINE (2007)
Bone regeneration is regulated by Wnt signaling
Jae-Beorn Kim et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone
Oxana P. Lazarenko et al.
ENDOCRINOLOGY (2007)
The peroxisome proliferator-activated receptor-γ agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women:: A randomized, controlled trial
Andrew Grey et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Inhibin A is an endocrine stimulator of bone mass and strength
Daniel S. Perrien et al.
ENDOCRINOLOGY (2007)
Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture
Mohsen Janghorbani et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
The Nicolas Andry Award - Modulation of distraction osteogenesis in the aged rat by fibroblast growth factor
J Aronson
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2004)
Enhanced marrow adipogenesis and bone resorption in estrogen-deprived rats treated with the PPARgamma agonist BRL49653 (rosiglitazone)
V Sottile et al.
CALCIFIED TISSUE INTERNATIONAL (2004)
Establishment of a model of cortical bone repair in mice
TM Campbell et al.
CALCIFIED TISSUE INTERNATIONAL (2003)
Divergent effects of selective peroxisome proliferator-activated receptor-γ2 ligands on adipocyte versus osteoblast differentiation
B Lecka-Czernik et al.
ENDOCRINOLOGY (2002)
PPAR activators inhibit endothelial cell migration by targeting Akt
S Goetze et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Immunohistochemical study of osteopontin expression during distraction osteogenesis in the rat
DS Perrien et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2002)
Expression of vascular antigens by bone cells during bone regeneration in a membranous bone distraction system
D Lewinson et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2001)
Share Paper
